RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York